CPC860 (PHENAZOPYRIDINE 200 mg)
Pill imprint CPC860 has been identified as Phenazopyridine hydrochloride 200 mg.
Phenazopyridine is used in the treatment of interstitial cystitis; dysuria and belongs to the drug class miscellaneous genitourinary tract agents. There is no proven risk in humans during pregnancy. Phenazopyridine 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for CPC860 (PHENAZOPYRIDINE 200 mg)
- 200 mg
- 19.00 mm
- Rx and/or OTC
- Drug Class:
- Miscellaneous genitourinary tract agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Breckenridge Pharmaceutical, Inc.
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|10267-0860||Contract Pharmacal Corporation|
|64376-0812||Boca Pharmacal Inc|
|54569-0197||A S Medication Solutions LLC (repackager)|
|21695-0301||Rebel Distributors Corp (repackager)|
|66336-0105||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
More about phenazopyridine
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...